Filing search / Iovance Biotherapeutics, Inc. / "Voting Rights" / Page 2

424B5

f74teccumj53757sfe

18 Nov 22

Prospectus supplement for primary offering

5:14pm

8-K

EX-3.1

sbrs9h xx7

29 Apr 22

Amendments to Articles of Incorporation or Bylaws

5:12pm

8-K

EX-3.1

lqb9a

26 Apr 21

Amendments to Articles of Incorporation or Bylaws

12:00am

424B5

p4g8h9rnfxqa vctx4h0

9 Feb 21

Prospectus supplement for primary offering

6:45am

424B5

fjlu rlwfmf7llzqz

29 May 20

Prospectus supplement for primary offering

4:15pm

424B5

4gwiaz2r6q7u45tzb2

27 May 20

Prospectus supplement for primary offering

5:26pm

S-3ASR

smvtsqv9riyj

27 May 20

Automatic shelf registration

4:14pm

8-K

EX-3.1

dr6iat37j ncwv5e4b

27 May 20

Iovance Reports Pivotal Cohort 4 Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel from

4:02pm